MCL coexpression mm9:2852: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0004121!1.11e-30!95;UBERON:0000924!1.11e-30!95;UBERON:0006601!1.11e-30!95;UBERON:0001017!3.82e-30!73;UBERON:0001016!4.16e-30!75;UBERON:0002346!7.97e-27!64;UBERON:0003075!7.97e-27!64;UBERON:0007284!7.97e-27!64;UBERON:0010371!4.82e-25!73;UBERON:0000073!9.07e-24!54;UBERON:0001049!9.44e-23!52;UBERON:0005068!9.44e-23!52;UBERON:0006241!9.44e-23!52;UBERON:0007135!9.44e-23!52;UBERON:0000955!3.72e-19!47;UBERON:0006238!3.72e-19!47;UBERON:0003056!5.37e-19!49;UBERON:0002616!9.67e-19!46;UBERON:0010314!6.51e-17!92;UBERON:0003080!5.45e-16!40;UBERON:0002020!7.44e-16!34;UBERON:0002780!1.60e-15!39;UBERON:0001890!1.60e-15!39;UBERON:0006240!1.60e-15!39;UBERON:0003528!1.04e-12!29;UBERON:0002791!1.04e-12!29;UBERON:0001893!1.04e-12!29;UBERON:0000922!2.74e-09!320;UBERON:0000956!2.51e-08!21;UBERON:0001869!2.51e-08!21;UBERON:0000203!2.51e-08!21;UBERON:0000468!6.04e-08!333;UBERON:0003076!1.68e-07!12;UBERON:0003057!1.68e-07!12 | |ontology_enrichment_uberon=UBERON:0004121!1.11e-30!95;UBERON:0000924!1.11e-30!95;UBERON:0006601!1.11e-30!95;UBERON:0001017!3.82e-30!73;UBERON:0001016!4.16e-30!75;UBERON:0002346!7.97e-27!64;UBERON:0003075!7.97e-27!64;UBERON:0007284!7.97e-27!64;UBERON:0010371!4.82e-25!73;UBERON:0000073!9.07e-24!54;UBERON:0001049!9.44e-23!52;UBERON:0005068!9.44e-23!52;UBERON:0006241!9.44e-23!52;UBERON:0007135!9.44e-23!52;UBERON:0000955!3.72e-19!47;UBERON:0006238!3.72e-19!47;UBERON:0003056!5.37e-19!49;UBERON:0002616!9.67e-19!46;UBERON:0010314!6.51e-17!92;UBERON:0003080!5.45e-16!40;UBERON:0002020!7.44e-16!34;UBERON:0002780!1.60e-15!39;UBERON:0001890!1.60e-15!39;UBERON:0006240!1.60e-15!39;UBERON:0003528!1.04e-12!29;UBERON:0002791!1.04e-12!29;UBERON:0001893!1.04e-12!29;UBERON:0000922!2.74e-09!320;UBERON:0000956!2.51e-08!21;UBERON:0001869!2.51e-08!21;UBERON:0000203!2.51e-08!21;UBERON:0000468!6.04e-08!333;UBERON:0003076!1.68e-07!12;UBERON:0003057!1.68e-07!12 | ||
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,1.23467,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,1.138,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,5.11274,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,0.444545,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.922882,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,1.6706,0.474956,0.777706,1.44925,4.93332,1.03818,0.411601,1.04436,1.20986,0.684144,0.476502,2.61188,1.00151,0.459035,1.32978,3.0674,0.195254,0.99201,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,1.31639,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,2.53104,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,1.45847,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,1.44008,0.38417,2.0485,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.833542 | |||
}} | }} |
Revision as of 22:02, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr13:48356475..48356492,+ | p1@Id4 |
Mm9::chr2:20890358..20890371,+ | p3@Gm13375 |
Mm9::chr4:41587355..41587377,- | p1@ENSMUST00000127306 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0048712 | negative regulation of astrocyte differentiation | 0.00405412808853339 |
GO:0048710 | regulation of astrocyte differentiation | 0.00405412808853339 |
GO:0021766 | hippocampus development | 0.00405412808853339 |
GO:0014014 | negative regulation of gliogenesis | 0.00405412808853339 |
GO:0045686 | negative regulation of glial cell differentiation | 0.00405412808853339 |
GO:0048708 | astrocyte differentiation | 0.00405412808853339 |
GO:0045685 | regulation of glial cell differentiation | 0.00405412808853339 |
GO:0021895 | cerebral cortex neuron differentiation | 0.00405412808853339 |
GO:0014013 | regulation of gliogenesis | 0.00405412808853339 |
GO:0021761 | limbic system development | 0.00405412808853339 |
GO:0021543 | pallium development | 0.00515979938540614 |
GO:0045665 | negative regulation of neuron differentiation | 0.00540550411804453 |
GO:0021537 | telencephalon development | 0.0068413411494001 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.0068413411494001 |
GO:0007405 | neuroblast proliferation | 0.0068413411494001 |
GO:0045664 | regulation of neuron differentiation | 0.0068413411494001 |
GO:0010001 | glial cell differentiation | 0.00831096258149346 |
GO:0042063 | gliogenesis | 0.00831096258149346 |
GO:0051325 | interphase | 0.00831096258149346 |
GO:0051329 | interphase of mitotic cell cycle | 0.00831096258149346 |
GO:0045596 | negative regulation of cell differentiation | 0.0164095660726352 |
GO:0030900 | forebrain development | 0.0183317096177162 |
GO:0051093 | negative regulation of developmental process | 0.0183317096177162 |
GO:0045595 | regulation of cell differentiation | 0.0258450665644004 |
GO:0008284 | positive regulation of cell proliferation | 0.0285410617432751 |
GO:0007420 | brain development | 0.028690752626544 |
GO:0000278 | mitotic cell cycle | 0.0334465567304005 |
GO:0007417 | central nervous system development | 0.0334465567304005 |
GO:0050793 | regulation of developmental process | 0.0357881651953293 |
GO:0022403 | cell cycle phase | 0.0362255961459274 |
GO:0030182 | neuron differentiation | 0.0362255961459274 |
GO:0048699 | generation of neurons | 0.0389442001231844 |
GO:0042127 | regulation of cell proliferation | 0.0389442001231844 |
GO:0022008 | neurogenesis | 0.040302802762479 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
ectodermal cell | 4.34e-19 | 44 |
neurectodermal cell | 4.34e-19 | 44 |
neural cell | 2.01e-18 | 43 |
CNS neuron (sensu Vertebrata) | 2.81e-15 | 23 |
neuroblast (sensu Vertebrata) | 2.81e-15 | 23 |
neuron | 1.44e-14 | 33 |
neuronal stem cell | 1.44e-14 | 33 |
neuroblast | 1.44e-14 | 33 |
electrically signaling cell | 1.44e-14 | 33 |
non-terminally differentiated cell | 3.36e-14 | 49 |
electrically responsive cell | 1.78e-10 | 39 |
electrically active cell | 1.78e-10 | 39 |
Ontology term | p-value | n |
---|---|---|
ectoderm-derived structure | 1.11e-30 | 95 |
ectoderm | 1.11e-30 | 95 |
presumptive ectoderm | 1.11e-30 | 95 |
central nervous system | 3.82e-30 | 73 |
nervous system | 4.16e-30 | 75 |
neurectoderm | 7.97e-27 | 64 |
neural plate | 7.97e-27 | 64 |
presumptive neural plate | 7.97e-27 | 64 |
ecto-epithelium | 4.82e-25 | 73 |
regional part of nervous system | 9.07e-24 | 54 |
neural tube | 9.44e-23 | 52 |
neural rod | 9.44e-23 | 52 |
future spinal cord | 9.44e-23 | 52 |
neural keel | 9.44e-23 | 52 |
brain | 3.72e-19 | 47 |
future brain | 3.72e-19 | 47 |
pre-chordal neural plate | 5.37e-19 | 49 |
regional part of brain | 9.67e-19 | 46 |
structure with developmental contribution from neural crest | 6.51e-17 | 92 |
anterior neural tube | 5.45e-16 | 40 |
gray matter | 7.44e-16 | 34 |
regional part of forebrain | 1.60e-15 | 39 |
forebrain | 1.60e-15 | 39 |
future forebrain | 1.60e-15 | 39 |
brain grey matter | 1.04e-12 | 29 |
regional part of telencephalon | 1.04e-12 | 29 |
telencephalon | 1.04e-12 | 29 |
embryo | 2.74e-09 | 320 |
cerebral cortex | 2.51e-08 | 21 |
cerebral hemisphere | 2.51e-08 | 21 |
pallium | 2.51e-08 | 21 |
multi-cellular organism | 6.04e-08 | 333 |
posterior neural tube | 1.68e-07 | 12 |
chordal neural plate | 1.68e-07 | 12 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |